Introducing HEMA HISS: the next-level 2-Hydroxyethyl Methacrylate
Author: Felix Adam
If standard HEMA already drives performance in hydrogels, coatings and dental resins, HEMA HISS (High-Inhibitor-Stripped & Super-dry) takes those advantages up a notch. Produced by extra vacuum-distillation and inhibitor-stripping steps, HEMA HISS delivers ≥ 99.5 % monomer purity, ≤ 50 ppm MEHQ, ≤ 0.05 % water and ultra-low residual acid. For formulators chasing crystal clarity, faster UV/EB cure and medical-grade cleanliness, this specification is a game-changer.
Where HEMA HISS excels
In ophthalmic and contact-lens production, lower water and inhibitor loads translate into superior transparency, higher molecular weight polymers and fewer extractables—critical for long-wear lenses. Clear 3D-printing resins benefit because the near-inhibitor-free profile lets photoinitiators activate instantly, shortening layer times and boosting green strength without yellowing. High-gloss UV or EB-curable coatings see fewer pinholes and bubbles thanks to ultra-low acid and water, while faster cure speeds lift line productivity in packaging, electronics and wood finishing. Biomedical hydrogels gain from consistent polymerisation kinetics and trace-impurity certificates that smooth ISO 10993 and USP Class VI submissions. Dental and composite adhesives enjoy longer shelf stability and colour retention, key for invisible fillings and orthodontic brackets.
Five performance advantages over normal HEMA
First, the dramatically lower inhibitor level means faster polymerisation and reduced photoinitiator cost. Second, sub-20 APHA colour and ultra-low moisture eliminate haze and yellowing, delivering optical-grade clarity. Third, fewer chain stoppers allow longer polymer chains, producing tougher, more flexible films and gels. Fourth, minimal acid and water slow premature crosslinking in two-part systems, extending pot life. Fifth, the extra purification yields rock-solid batch-to-batch certificates of analysis that simplify regulatory filings and shorten time-to-market.
Who gladly pays the premium
Companies that convert purity into profit jump first: contact-lens manufacturers avoid costly rejects; dental material formulators demand colourless, biocompatible monomers; industrial UV-coating producers offset the price delta with faster cure and less rework; innovative 3D-printing resin brands tout “near-zero inhibitor” accuracy; and medical-device OEMs value reduced validation headaches far more than a few extra cents per kilogram.
Calculating the return
Imagine a lens formulation containing 40 percent HEMA. Swapping technical grade for HISS adds just €0.12 to each lens blank, yet if purity cuts QC rejects from four percent to two percent, scrap savings reach €0.18 per blank—net positive even before counting productivity gains.
Safe handling and storage
Shipping HEMA HISS and storing happens under nitrogen below 25 °C in stainless-steel or glass-lined vessels, and avoid copper or brass. Maintain inert-gas blanketing during transfers to prevent spontaneous polymerisation, and add a stabiliser such as MEHQ or phenothiazine if long-term storage beyond three months is unavoidable.
Ready to upgrade?
If your profitability relies on optical clarity, medical compliance, lightning-fast UV cure or reduced scrap, HEMA HISS pays for itself many times over. Chemicals United stocks fresh, nitrogen-blanketed material in 190-kg drums, one-tonne IBCs and isotanks, shipping ex Rotterdam or DDP to most EU destinations within four days. Contact our Strategic Sales & Innovation team to discuss trial drums, bulk contracts or custom inhibitor packages—and elevate your formulations with the ultra-pure monomer engineered for tomorrow’s lenses, resins and hydrogels.The body content of your post goes here. To edit this text, click on it and delete this default text and start typing your own or paste your own from a different source.